Walsh & Associates’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Walsh & Associates's BMY Position: Q3 2026 in Review
Walsh & Associates opened a new position in Bristol-Myers Squibb (BMY) in Q3 2026: 50 shares worth $3.12K. The stake represents ﹤0.01% of the portfolio and ranks #233 among its holdings.
2,569 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Walsh & Associates held 50 shares of Bristol-Myers Squibb worth $3.12K as of Q3 2026.
- Bristol-Myers Squibb was a new Walsh & Associates position in Q3 2026.
- Bristol-Myers Squibb made up ﹤0.01% of Walsh & Associates's portfolio in Q3 2026, its #233 holding.
- 2,569 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Walsh & Associates's 13F filing for Q3 2026, filed 9 Nov 2026.